Elligo Health Research

Elligo Health Research

Elligo Health Research is an Austin-based clinical trial services firm that integrates research directly into real-world healthcare delivery. Its model supports sponsors, CROs, and sites by embedding studies within existing clinical workflows, aiming to accelerate startup timelines and broaden patient access. The firm provides a full spectrum of clinical trial services: site activation with staffing and technology integration, decentralized trial solutions for virtual, hybrid, and traditional studies, patient recruitment campaigns executed across 28 countries and 200+ trials, and global retention services in 38+ countries. Elligo emphasizes real-world patient connections through bilingual pre-screening, study branding, and concierge-level travel support and rapid reimbursements. It claims a 93% post-randomization retention rate. Elligo does not publicly disclose its founding year, team size, revenue, or ownership structure. Its website highlights a patient testimonial from a diabetes trial participant named Shawn, a vaccine trial participant named Ruben, and a cancer screening trial participant named Kirsten. The firm publishes resources on patient recruitment and retention, including articles on EHR optimization and decentralized strategies for liquid biopsy clinical studies. The firm's structural differentiator is its integration of research into routine healthcare delivery via a network of research-ready sites, contrasting with traditional models that separate clinical care from trial operations. By positioning itself as a single partner covering site activation, recruitment, and retention, Elligo aims to streamline sponsors' and CROs' operational complexity. Its ownership and governance structure are not publicly disclosed.